Agile Therapeutics, Inc. (AGRX): Price and Financial Metrics


Agile Therapeutics, Inc. (AGRX): $1.03

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AGRX POWR Grades


  • Sentiment is the dimension where AGRX ranks best; there it ranks ahead of 81.57% of US stocks.
  • AGRX's strongest trending metric is Value; it's been moving up over the last 48 weeks.
  • AGRX's current lowest rank is in the Momentum metric (where it is better than 9.48% of US stocks).

AGRX Stock Summary

  • AGRX's price/sales ratio is 46.73; that's higher than the P/S ratio of 94.57% of US stocks.
  • Revenue growth over the past 12 months for Agile Therapeutics Inc comes in at 173.7%, a number that bests 95.97% of the US stocks we're tracking.
  • In terms of volatility of its share price, AGRX is more volatile than 95.66% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Agile Therapeutics Inc, a group of peers worth examining would be NBRV, SSD, MYO, LMAT, and ISR.
  • Visit AGRX's SEC page to see the company's official filings. To visit the company's web site, go to www.agiletherapeutics.com.

AGRX Valuation Summary

  • In comparison to the median Healthcare stock, AGRX's price/sales ratio is 1284.21% higher, now standing at 52.6.
  • AGRX's price/sales ratio has moved NA NA over the prior 89 months.
  • AGRX's price/earnings ratio has moved up 4 over the prior 89 months.

Below are key valuation metrics over time for AGRX.

Stock Date P/S P/B P/E EV/EBIT
AGRX 2021-08-31 52.6 4.4 -1.6 -1.5
AGRX 2021-08-30 53.5 4.5 -1.6 -1.6
AGRX 2021-08-27 50.3 4.2 -1.5 -1.5
AGRX 2021-08-26 49.5 4.1 -1.5 -1.4
AGRX 2021-08-25 48.5 4.0 -1.5 -1.4
AGRX 2021-08-24 47.6 4.0 -1.4 -1.4

AGRX Growth Metrics

  • Its 3 year cash and equivalents growth rate is now at -82.35%.
  • Its 2 year net income to common stockholders growth rate is now at 21%.
  • The 4 year net income to common stockholders growth rate now stands at 25.05%.
AGRX's revenue has moved up $2,050,000 over the prior 33 months.

The table below shows AGRX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 2.05 -62.666 -67.909
2021-03-31 0.865 -54.095 -61.098
2020-12-31 0.749 -47.311 -51.853
2020-09-30 0 -33.239 -40.254
2020-06-30 0 -22.999 -29.162
2020-03-31 0 -18.612 -21.82

AGRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AGRX has a Quality Grade of D, ranking ahead of 18.09% of graded US stocks.
  • AGRX's asset turnover comes in at 0.03 -- ranking 353rd of 677 Pharmaceutical Products stocks.
  • EVOK, EVFM, and HGEN are the stocks whose asset turnover ratios are most correlated with AGRX.

The table below shows AGRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.030 -0.262 -1.156
2021-03-31 0.011 -0.668 -0.869
2020-12-31 0.008 0.623 -0.805
2020-09-30 0.000 NA -0.818
2020-06-30 0.000 NA -0.888
2020-03-31 0.000 NA -1.312

AGRX Price Target

For more insight on analysts targets of AGRX, see our AGRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.00 Average Broker Recommendation 1.25 (Strong Buy)

AGRX Stock Price Chart Interactive Chart >

Price chart for AGRX

AGRX Price/Volume Stats

Current price $1.03 52-week high $3.77
Prev. close $1.03 52-week low $0.93
Day low $1.02 Volume 403,265
Day high $1.05 Avg. volume 1,147,936
50-day MA $1.12 Dividend yield N/A
200-day MA $1.93 Market Cap 95.79M

Agile Therapeutics, Inc. (AGRX) Company Bio


Agile Therapeutics, Inc. focuses on the development and commercialization of prescription contraceptive products for women. The company was founded in 1997 and is based in Princeton, New Jersey.


AGRX Latest News Stream


Event/Time News Detail
Loading, please wait...

AGRX Latest Social Stream


Loading social stream, please wait...

View Full AGRX Social Stream

Latest AGRX News From Around the Web

Below are the latest news stories about Agile Therapeutics Inc that investors may wish to consider to help them evaluate AGRX as an investment opportunity.

Agile Therapeutics to Participate in Upcoming Investor Conferences

PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the following virtual investor conferences during the month of September 2021. H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021) Date: On-Demand Beginning Monday, September 13, 2021 at 7 a.m. ETWebcast: https://journey.ct.events/view/f135776a-907f-4644-bb11-7c4619d6cabf Oppenheimer

Yahoo | September 7, 2021

Women Health Services Market 2021 Current Development Explored with Leading Players | Bayer AG (Germany), Allergan, Merck & Co., Pfizer Inc. (US), Amgen, Agile Therapeutics Inc., Ferring Pharmaceuticals

The Women Health Services Market size was estimated at $32.4 billion in 2021, projected to grow at a CAGR of 5.5% during the forecast period 2021-2028 Women Health Services is the field of medicine concerned with the prevention and diagnosis of

OpenPR | August 30, 2021

Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women''s Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system

Pandia Health is a doctor founded and led telehealth company, offering online prescriptions and free delivery designed to make it easier for women to access birth control options that meet their needs Partnership represents first telehealth alliance for Agile''s Twirla ® birth control patch PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ: AGRX ), a women''s healthcare company, today announced a partnership with Pandia Health, an online telehealth service, which will establish the first telehealth relationship for Agile and offer an additional point of access to Twirla ® (levonorgestrel and ethinyl estradiol) transdermal system in a fast-growing channel. Pandia Health offers convenient prescription fulfillment for women with active birth control prescr...

Benzinga | August 20, 2021

Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Womens Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system

PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women''s healthcare company, today announced a partnership with Pandia Health, an online telehealth service, which will establish the first telehealth relationship for Agile and offer an additional point of access to Twirla ® (levonorgestrel and ethinyl estradiol) transdermal system in a fast-growing channel.

Intrado Digital Media | August 20, 2021

Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women’s Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system

Pandia Health is a doctor founded and led telehealth company, offering online prescriptions and free delivery designed to make it easier for women to access birth control options that meet their needsPartnership represents first telehealth alliance for Agile’s Twirla® birth control patch PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth service, which wil

Yahoo | August 20, 2021

Read More 'AGRX' Stories Here

AGRX Price Returns

1-mo -1.90%
3-mo -23.70%
6-mo -49.76%
1-year -63.99%
3-year 202.94%
5-year -85.79%
YTD -64.11%
2020 14.80%
2019 331.03%
2018 -78.44%
2017 -52.81%
2016 -41.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0003 seconds.